ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Psoriasis Biologics Drugs Market Research Report 2025
Published Date: February 2025
|
Report Code: QYRE-Auto-3B12574
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Psoriasis Biologics Drugs Market Research Report 2022
BUY CHAPTERS

Global Psoriasis Biologics Drugs Market Research Report 2025

Code: QYRE-Auto-3B12574
Report
February 2025
Pages:84
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Johnson & Johnson
Abbive
Innovent
BIOCAD
Novartis
Eli Lilly
Sun Pharmaceutical
Amgen Inc
UCB

Psoriasis Biologics Drugs Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Psoriasis Biologics Drugs Market

Psoriasis Biologics Drugs Market

The global market for Psoriasis Biologics Drugs was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Psoriasis Biologics Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Psoriasis Biologics Drugs.
The Psoriasis Biologics Drugs market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Psoriasis Biologics Drugs market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Psoriasis Biologics Drugs manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Psoriasis Biologics Drugs Market Report

Report Metric Details
Report Name Psoriasis Biologics Drugs Market
CAGR 5%
Segment by Type
  • TNF-α Inhibitor
  • IL-12/23 Target Drug
  • IL-17 Target Drug
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Amgen, UCB, Johnson & Johnson, Abbive, Innovent, Biocad, Novartis, Eli Lilly, Sun Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Psoriasis Biologics Drugs manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Psoriasis Biologics Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Psoriasis Biologics Drugs Market report?

Ans: The main players in the Psoriasis Biologics Drugs Market are Amgen, UCB, Johnson & Johnson, Abbive, Innovent, Biocad, Novartis, Eli Lilly, Sun Pharmaceutical

What are the Application segmentation covered in the Psoriasis Biologics Drugs Market report?

Ans: The Applications covered in the Psoriasis Biologics Drugs Market report are Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

What are the Type segmentation covered in the Psoriasis Biologics Drugs Market report?

Ans: The Types covered in the Psoriasis Biologics Drugs Market report are TNF-α Inhibitor, IL-12/23 Target Drug, IL-17 Target Drug

Recommended Reports

Immunology & Biologics

Dermatology & Inflammatory

Pharmaceuticals Market

1 Psoriasis Biologics Drugs Market Overview
1.1 Product Definition
1.2 Psoriasis Biologics Drugs by Type
1.2.1 Global Psoriasis Biologics Drugs Market Value Comparison by Type (2024 VS 2031)
1.2.2 TNF-α Inhibitor
1.2.3 IL-12/23 Target Drug
1.2.4 IL-17 Target Drug
1.3 Psoriasis Biologics Drugs by Application
1.3.1 Global Psoriasis Biologics Drugs Market Value by Application (2024 VS 2031)
1.3.2 Hospital Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Online Pharmacies
1.4 Global Psoriasis Biologics Drugs Market Size Estimates and Forecasts
1.4.1 Global Psoriasis Biologics Drugs Revenue 2020-2031
1.4.2 Global Psoriasis Biologics Drugs Sales 2020-2031
1.4.3 Global Psoriasis Biologics Drugs Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Psoriasis Biologics Drugs Market Competition by Manufacturers
2.1 Global Psoriasis Biologics Drugs Sales Market Share by Manufacturers (2020-2025)
2.2 Global Psoriasis Biologics Drugs Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Psoriasis Biologics Drugs Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Psoriasis Biologics Drugs, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Psoriasis Biologics Drugs, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Psoriasis Biologics Drugs, Product Type & Application
2.7 Global Key Manufacturers of Psoriasis Biologics Drugs, Date of Enter into This Industry
2.8 Global Psoriasis Biologics Drugs Market Competitive Situation and Trends
2.8.1 Global Psoriasis Biologics Drugs Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Psoriasis Biologics Drugs Players Market Share by Revenue
2.8.3 Global Psoriasis Biologics Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Psoriasis Biologics Drugs Market Scenario by Region
3.1 Global Psoriasis Biologics Drugs Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Psoriasis Biologics Drugs Sales by Region: 2020-2031
3.2.1 Global Psoriasis Biologics Drugs Sales by Region: 2020-2025
3.2.2 Global Psoriasis Biologics Drugs Sales by Region: 2026-2031
3.3 Global Psoriasis Biologics Drugs Revenue by Region: 2020-2031
3.3.1 Global Psoriasis Biologics Drugs Revenue by Region: 2020-2025
3.3.2 Global Psoriasis Biologics Drugs Revenue by Region: 2026-2031
3.4 North America Psoriasis Biologics Drugs Market Facts & Figures by Country
3.4.1 North America Psoriasis Biologics Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Psoriasis Biologics Drugs Sales by Country (2020-2031)
3.4.3 North America Psoriasis Biologics Drugs Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Psoriasis Biologics Drugs Market Facts & Figures by Country
3.5.1 Europe Psoriasis Biologics Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Psoriasis Biologics Drugs Sales by Country (2020-2031)
3.5.3 Europe Psoriasis Biologics Drugs Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Psoriasis Biologics Drugs Market Facts & Figures by Region
3.6.1 Asia Pacific Psoriasis Biologics Drugs Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Psoriasis Biologics Drugs Sales by Region (2020-2031)
3.6.3 Asia Pacific Psoriasis Biologics Drugs Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Psoriasis Biologics Drugs Market Facts & Figures by Country
3.7.1 Latin America Psoriasis Biologics Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Psoriasis Biologics Drugs Sales by Country (2020-2031)
3.7.3 Latin America Psoriasis Biologics Drugs Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Psoriasis Biologics Drugs Market Facts & Figures by Country
3.8.1 Middle East and Africa Psoriasis Biologics Drugs Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Psoriasis Biologics Drugs Sales by Country (2020-2031)
3.8.3 Middle East and Africa Psoriasis Biologics Drugs Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Psoriasis Biologics Drugs Sales by Type (2020-2031)
4.1.1 Global Psoriasis Biologics Drugs Sales by Type (2020-2025)
4.1.2 Global Psoriasis Biologics Drugs Sales by Type (2026-2031)
4.1.3 Global Psoriasis Biologics Drugs Sales Market Share by Type (2020-2031)
4.2 Global Psoriasis Biologics Drugs Revenue by Type (2020-2031)
4.2.1 Global Psoriasis Biologics Drugs Revenue by Type (2020-2025)
4.2.2 Global Psoriasis Biologics Drugs Revenue by Type (2026-2031)
4.2.3 Global Psoriasis Biologics Drugs Revenue Market Share by Type (2020-2031)
4.3 Global Psoriasis Biologics Drugs Price by Type (2020-2031)
5 Segment by Application
5.1 Global Psoriasis Biologics Drugs Sales by Application (2020-2031)
5.1.1 Global Psoriasis Biologics Drugs Sales by Application (2020-2025)
5.1.2 Global Psoriasis Biologics Drugs Sales by Application (2026-2031)
5.1.3 Global Psoriasis Biologics Drugs Sales Market Share by Application (2020-2031)
5.2 Global Psoriasis Biologics Drugs Revenue by Application (2020-2031)
5.2.1 Global Psoriasis Biologics Drugs Revenue by Application (2020-2025)
5.2.2 Global Psoriasis Biologics Drugs Revenue by Application (2026-2031)
5.2.3 Global Psoriasis Biologics Drugs Revenue Market Share by Application (2020-2031)
5.3 Global Psoriasis Biologics Drugs Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Amgen
6.1.1 Amgen Company Information
6.1.2 Amgen Description and Business Overview
6.1.3 Amgen Psoriasis Biologics Drugs Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Amgen Psoriasis Biologics Drugs Product Portfolio
6.1.5 Amgen Recent Developments/Updates
6.2 UCB
6.2.1 UCB Company Information
6.2.2 UCB Description and Business Overview
6.2.3 UCB Psoriasis Biologics Drugs Sales, Revenue and Gross Margin (2020-2025)
6.2.4 UCB Psoriasis Biologics Drugs Product Portfolio
6.2.5 UCB Recent Developments/Updates
6.3 Johnson & Johnson
6.3.1 Johnson & Johnson Company Information
6.3.2 Johnson & Johnson Description and Business Overview
6.3.3 Johnson & Johnson Psoriasis Biologics Drugs Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Johnson & Johnson Psoriasis Biologics Drugs Product Portfolio
6.3.5 Johnson & Johnson Recent Developments/Updates
6.4 Abbive
6.4.1 Abbive Company Information
6.4.2 Abbive Description and Business Overview
6.4.3 Abbive Psoriasis Biologics Drugs Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Abbive Psoriasis Biologics Drugs Product Portfolio
6.4.5 Abbive Recent Developments/Updates
6.5 Innovent
6.5.1 Innovent Company Information
6.5.2 Innovent Description and Business Overview
6.5.3 Innovent Psoriasis Biologics Drugs Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Innovent Psoriasis Biologics Drugs Product Portfolio
6.5.5 Innovent Recent Developments/Updates
6.6 Biocad
6.6.1 Biocad Company Information
6.6.2 Biocad Description and Business Overview
6.6.3 Biocad Psoriasis Biologics Drugs Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Biocad Psoriasis Biologics Drugs Product Portfolio
6.6.5 Biocad Recent Developments/Updates
6.7 Novartis
6.7.1 Novartis Company Information
6.7.2 Novartis Description and Business Overview
6.7.3 Novartis Psoriasis Biologics Drugs Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Novartis Psoriasis Biologics Drugs Product Portfolio
6.7.5 Novartis Recent Developments/Updates
6.8 Eli Lilly
6.8.1 Eli Lilly Company Information
6.8.2 Eli Lilly Description and Business Overview
6.8.3 Eli Lilly Psoriasis Biologics Drugs Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Eli Lilly Psoriasis Biologics Drugs Product Portfolio
6.8.5 Eli Lilly Recent Developments/Updates
6.9 Sun Pharmaceutical
6.9.1 Sun Pharmaceutical Company Information
6.9.2 Sun Pharmaceutical Description and Business Overview
6.9.3 Sun Pharmaceutical Psoriasis Biologics Drugs Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Sun Pharmaceutical Psoriasis Biologics Drugs Product Portfolio
6.9.5 Sun Pharmaceutical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Psoriasis Biologics Drugs Industry Chain Analysis
7.2 Psoriasis Biologics Drugs Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Psoriasis Biologics Drugs Production Mode & Process Analysis
7.4 Psoriasis Biologics Drugs Sales and Marketing
7.4.1 Psoriasis Biologics Drugs Sales Channels
7.4.2 Psoriasis Biologics Drugs Distributors
7.5 Psoriasis Biologics Drugs Customer Analysis
8 Psoriasis Biologics Drugs Market Dynamics
8.1 Psoriasis Biologics Drugs Industry Trends
8.2 Psoriasis Biologics Drugs Market Drivers
8.3 Psoriasis Biologics Drugs Market Challenges
8.4 Psoriasis Biologics Drugs Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Johnson & Johnson
Abbive
Innovent
BIOCAD
Novartis
Eli Lilly
Sun Pharmaceutical
Amgen Inc
UCB
List of Tables
 Table 1. Global Psoriasis Biologics Drugs Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Psoriasis Biologics Drugs Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Psoriasis Biologics Drugs Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Psoriasis Biologics Drugs Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Psoriasis Biologics Drugs Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Psoriasis Biologics Drugs Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Psoriasis Biologics Drugs Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Psoriasis Biologics Drugs Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Psoriasis Biologics Drugs, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Psoriasis Biologics Drugs, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Psoriasis Biologics Drugs, Product Type & Application
 Table 12. Global Key Manufacturers of Psoriasis Biologics Drugs, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Psoriasis Biologics Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Psoriasis Biologics Drugs as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Psoriasis Biologics Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Psoriasis Biologics Drugs Sales by Region (2020-2025) & (K Units)
 Table 18. Global Psoriasis Biologics Drugs Sales Market Share by Region (2020-2025)
 Table 19. Global Psoriasis Biologics Drugs Sales by Region (2026-2031) & (K Units)
 Table 20. Global Psoriasis Biologics Drugs Sales Market Share by Region (2026-2031)
 Table 21. Global Psoriasis Biologics Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Psoriasis Biologics Drugs Revenue Market Share by Region (2020-2025)
 Table 23. Global Psoriasis Biologics Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Psoriasis Biologics Drugs Revenue Market Share by Region (2026-2031)
 Table 25. North America Psoriasis Biologics Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Psoriasis Biologics Drugs Sales by Country (2020-2025) & (K Units)
 Table 27. North America Psoriasis Biologics Drugs Sales by Country (2026-2031) & (K Units)
 Table 28. North America Psoriasis Biologics Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Psoriasis Biologics Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Psoriasis Biologics Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Psoriasis Biologics Drugs Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Psoriasis Biologics Drugs Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Psoriasis Biologics Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Psoriasis Biologics Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Psoriasis Biologics Drugs Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Psoriasis Biologics Drugs Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Psoriasis Biologics Drugs Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Psoriasis Biologics Drugs Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Psoriasis Biologics Drugs Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Psoriasis Biologics Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Psoriasis Biologics Drugs Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Psoriasis Biologics Drugs Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Psoriasis Biologics Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Psoriasis Biologics Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Psoriasis Biologics Drugs Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Psoriasis Biologics Drugs Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Psoriasis Biologics Drugs Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Psoriasis Biologics Drugs Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Psoriasis Biologics Drugs Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Psoriasis Biologics Drugs Sales (K Units) by Type (2020-2025)
 Table 51. Global Psoriasis Biologics Drugs Sales (K Units) by Type (2026-2031)
 Table 52. Global Psoriasis Biologics Drugs Sales Market Share by Type (2020-2025)
 Table 53. Global Psoriasis Biologics Drugs Sales Market Share by Type (2026-2031)
 Table 54. Global Psoriasis Biologics Drugs Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Psoriasis Biologics Drugs Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Psoriasis Biologics Drugs Revenue Market Share by Type (2020-2025)
 Table 57. Global Psoriasis Biologics Drugs Revenue Market Share by Type (2026-2031)
 Table 58. Global Psoriasis Biologics Drugs Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Psoriasis Biologics Drugs Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Psoriasis Biologics Drugs Sales (K Units) by Application (2020-2025)
 Table 61. Global Psoriasis Biologics Drugs Sales (K Units) by Application (2026-2031)
 Table 62. Global Psoriasis Biologics Drugs Sales Market Share by Application (2020-2025)
 Table 63. Global Psoriasis Biologics Drugs Sales Market Share by Application (2026-2031)
 Table 64. Global Psoriasis Biologics Drugs Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Psoriasis Biologics Drugs Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Psoriasis Biologics Drugs Revenue Market Share by Application (2020-2025)
 Table 67. Global Psoriasis Biologics Drugs Revenue Market Share by Application (2026-2031)
 Table 68. Global Psoriasis Biologics Drugs Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Psoriasis Biologics Drugs Price (US$/Unit) by Application (2026-2031)
 Table 70. Amgen Company Information
 Table 71. Amgen Description and Business Overview
 Table 72. Amgen Psoriasis Biologics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Amgen Psoriasis Biologics Drugs Product
 Table 74. Amgen Recent Developments/Updates
 Table 75. UCB Company Information
 Table 76. UCB Description and Business Overview
 Table 77. UCB Psoriasis Biologics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. UCB Psoriasis Biologics Drugs Product
 Table 79. UCB Recent Developments/Updates
 Table 80. Johnson & Johnson Company Information
 Table 81. Johnson & Johnson Description and Business Overview
 Table 82. Johnson & Johnson Psoriasis Biologics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. Johnson & Johnson Psoriasis Biologics Drugs Product
 Table 84. Johnson & Johnson Recent Developments/Updates
 Table 85. Abbive Company Information
 Table 86. Abbive Description and Business Overview
 Table 87. Abbive Psoriasis Biologics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Abbive Psoriasis Biologics Drugs Product
 Table 89. Abbive Recent Developments/Updates
 Table 90. Innovent Company Information
 Table 91. Innovent Description and Business Overview
 Table 92. Innovent Psoriasis Biologics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Innovent Psoriasis Biologics Drugs Product
 Table 94. Innovent Recent Developments/Updates
 Table 95. Biocad Company Information
 Table 96. Biocad Description and Business Overview
 Table 97. Biocad Psoriasis Biologics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Biocad Psoriasis Biologics Drugs Product
 Table 99. Biocad Recent Developments/Updates
 Table 100. Novartis Company Information
 Table 101. Novartis Description and Business Overview
 Table 102. Novartis Psoriasis Biologics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Novartis Psoriasis Biologics Drugs Product
 Table 104. Novartis Recent Developments/Updates
 Table 105. Eli Lilly Company Information
 Table 106. Eli Lilly Description and Business Overview
 Table 107. Eli Lilly Psoriasis Biologics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Eli Lilly Psoriasis Biologics Drugs Product
 Table 109. Eli Lilly Recent Developments/Updates
 Table 110. Sun Pharmaceutical Company Information
 Table 111. Sun Pharmaceutical Description and Business Overview
 Table 112. Sun Pharmaceutical Psoriasis Biologics Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Sun Pharmaceutical Psoriasis Biologics Drugs Product
 Table 114. Sun Pharmaceutical Recent Developments/Updates
 Table 115. Key Raw Materials Lists
 Table 116. Raw Materials Key Suppliers Lists
 Table 117. Psoriasis Biologics Drugs Distributors List
 Table 118. Psoriasis Biologics Drugs Customers List
 Table 119. Psoriasis Biologics Drugs Market Trends
 Table 120. Psoriasis Biologics Drugs Market Drivers
 Table 121. Psoriasis Biologics Drugs Market Challenges
 Table 122. Psoriasis Biologics Drugs Market Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources
 Table 126. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Psoriasis Biologics Drugs
 Figure 2. Global Psoriasis Biologics Drugs Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Psoriasis Biologics Drugs Market Share by Type: 2024 & 2031
 Figure 4. TNF-α Inhibitor Product Picture
 Figure 5. IL-12/23 Target Drug Product Picture
 Figure 6. IL-17 Target Drug Product Picture
 Figure 7. Global Psoriasis Biologics Drugs Market Value by Application (2020-2031) & (US$ Million)
 Figure 8. Global Psoriasis Biologics Drugs Market Share by Application: 2024 & 2031
 Figure 9. Hospital Pharmacies
 Figure 10. Retail Pharmacies
 Figure 11. Online Pharmacies
 Figure 12. Global Psoriasis Biologics Drugs Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Psoriasis Biologics Drugs Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Psoriasis Biologics Drugs Sales (2020-2031) & (K Units)
 Figure 15. Global Psoriasis Biologics Drugs Average Price (US$/Unit) & (2020-2031)
 Figure 16. Psoriasis Biologics Drugs Report Years Considered
 Figure 17. Psoriasis Biologics Drugs Sales Share by Manufacturers in 2024
 Figure 18. Global Psoriasis Biologics Drugs Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Psoriasis Biologics Drugs Players: Market Share by Revenue in Psoriasis Biologics Drugs in 2024
 Figure 20. Psoriasis Biologics Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Psoriasis Biologics Drugs Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Psoriasis Biologics Drugs Sales Market Share by Country (2020-2031)
 Figure 23. North America Psoriasis Biologics Drugs Revenue Market Share by Country (2020-2031)
 Figure 24. United States Psoriasis Biologics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Psoriasis Biologics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Psoriasis Biologics Drugs Sales Market Share by Country (2020-2031)
 Figure 27. Europe Psoriasis Biologics Drugs Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Psoriasis Biologics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Psoriasis Biologics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Psoriasis Biologics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Psoriasis Biologics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Psoriasis Biologics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Psoriasis Biologics Drugs Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Psoriasis Biologics Drugs Revenue Market Share by Region (2020-2031)
 Figure 35. China Psoriasis Biologics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Psoriasis Biologics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Psoriasis Biologics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Psoriasis Biologics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Psoriasis Biologics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Psoriasis Biologics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Southeast Asia Psoriasis Biologics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Latin America Psoriasis Biologics Drugs Sales Market Share by Country (2020-2031)
 Figure 43. Latin America Psoriasis Biologics Drugs Revenue Market Share by Country (2020-2031)
 Figure 44. Mexico Psoriasis Biologics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 45. Brazil Psoriasis Biologics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Argentina Psoriasis Biologics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Middle East and Africa Psoriasis Biologics Drugs Sales Market Share by Country (2020-2031)
 Figure 48. Middle East and Africa Psoriasis Biologics Drugs Revenue Market Share by Country (2020-2031)
 Figure 49. Turkey Psoriasis Biologics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 50. Saudi Arabia Psoriasis Biologics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. UAE Psoriasis Biologics Drugs Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Global Sales Market Share of Psoriasis Biologics Drugs by Type (2020-2031)
 Figure 53. Global Revenue Market Share of Psoriasis Biologics Drugs by Type (2020-2031)
 Figure 54. Global Psoriasis Biologics Drugs Price (US$/Unit) by Type (2020-2031)
 Figure 55. Global Sales Market Share of Psoriasis Biologics Drugs by Application (2020-2031)
 Figure 56. Global Revenue Market Share of Psoriasis Biologics Drugs by Application (2020-2031)
 Figure 57. Global Psoriasis Biologics Drugs Price (US$/Unit) by Application (2020-2031)
 Figure 58. Psoriasis Biologics Drugs Value Chain
 Figure 59. Channels of Distribution (Direct Vs Distribution)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Psoriasis Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Psoriasis Treatment Drugs Market Research Report 2025
Psoriatic Arthritis Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Psoriatic Arthritis Treatment Drugs Market Research Report 2025
Biopharma Cosmetics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Biosimilars Follow on Biologics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Prescription Dermatology Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Generic Medicine Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Still s Disease Treatment Market Research Report 2025
Global Living Biological Drugs Market Research Report 2025
Global Autoimmune Diseases Treatment Market Research Report 2024
Global Bio Similars Subsequent Entry Biologic Market Research Report 2024
Global Prostate Cancer Diagnostics and Therapy Market Research Report 2024
Scar Removal Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Super Generic Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Immune Drugs Market Insights Forecast to 2030
Prostate Cancer Therapeutics Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Prostate Cancer Treatment Device Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global PD 1 and PD L1 Inhibitor Market Research Report 2025
Systemic Infection Treatment Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions